Author:
Peng Wenpeng,Chen Yizhe,Fan Hongde,Chen Shanshan,Wang Hui,Song Xiang
Abstract
Problems of rapid degradation and poor biocompatibility (endothelialization and hemocompatibility) limit magnesium (Mg) alloy’s further applications in vascular stents. To solve these problems, a novel composite coating was designed on Mg alloy via a two-step method. First, a Mg alloy sample was immersed in hydrofluoric acid. Then, a poly-l-lactic acid (PLLA) coating was made by ultrasonic atomization spraying with 5 and 10 layers (referred to as PLLA(5)-HF-Mg and PLLA(10)-HF-Mg). Characterizations were analyzed from the microstructure, element distribution, and wettability. The degradation behavior was tested with an electrochemical test and immersion test. Endothelialization was investigated using human umbilical vein endothelial cells (HUVECs). Hemocompatibility was examined with a platelet adhesion test. The results showed that the PLLA coating could not only cover the surface, but also could permeate through and cover the holes on the MgF2 layer, mechanically locked with the substrate. Thus, the composite coating had higher corrosion resistance. The PLLA/MgF2 coating, especially on PLLA(10)-HF-Mg, enhanced HUVECs’ viability and growth. While incubated with platelets, the PLLA/MgF2 coating, especially on PLLA(10)-HF-Mg, had the lowest platelet adhesion number and activity. Taken together, the novel PLLA/MgF2 coating controls Mg alloy’s degradation by spraying different layers of PLLA, resulting in better endothelialization and hemocompatibility, providing a promising candidate for cardiovascular stents.
Funder
National Natural Science Foundation Council of China
Young Elite Scientists Sponsorship Program by CAST
China Postdoctoral Science Foundation
Subject
General Materials Science
Reference56 articles.
1. (2020). The writing committee of the report on cardiovascular health diseases in China. Chin. Circ. J., 35, 833–854.
2. From sirolimus to the Cypher stent: Stages of the victory against restenosis;Fontes;Ann. Cardiol. Angeiol.,2004
3. Bioresorbable scaffolds for the treatment of in-stent restenosis;Dorr;Heart Vessel.,2015
4. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice—4-year results from a large 2-institutional cohort study;Wenaweser;J. Am. Coll. Cardiol.,2008
5. Beshchasna, N., Saqib, M., Kraskiewicz, H., Wasyluk, L., Kuzmin, O., Duta, O.C., Ficai, D., Ghizdavet, Z., Marin, A., and Ficai, A. (2020). Recent Advances in Manufacturing Innovative Stents. Pharmaceutics, 12.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献